Carisbamate Safety Study in Adult and Pediatric Subjects With Lennox-Gastaut Syndrome
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- SK Life Science, Inc.
- Study ID
- NCT04062981
- Phase
- PHASE1
- Status
- Completed
Conditions
- Lennox Gastaut Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Carisbamate — DRUGAn oral liquid formulation (20 mg/mL) of carisbamate (S-carisbamate)
Study Details
Open-label extension study from YKP509C001 to evaluate the safety and tolerability of carisbamate in subjects with Lennox-Gastaut Syndrome (LGS).
Key Dates
- Start date
- May 3, 2019
- Status verified
- Apr 2024
- Primary completion
- Dec 14, 2022
- Completion
- Dec 14, 2022
Study Design
- Enrollment
- 15 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Cohort ISubjects ≥ 18 years of age These subjects will reach maximum stable dose and continue onto YKP509C002.
- Experimental: Cohort IISubjects 12 to \<18 years of age These subjects will reach maximum stable dose and continue onto YKP509C002.
- Experimental: Cohort IIISubjects 6 to \<12 years of age These subjects will reach maximum stable dose and continue onto YKP509C002.
- Experimental: Cohort IVSubjects 2 to \<6 years of age These subjects will reach maximum stable dose and continue onto YKP509C002.
Primary Outcome Measure
Concomitant medication [ Time Frame: Up to 20 months ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Hospital | Baltimore | Maryland | 21210 | - |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | - |
| Oregon Health and Science University | Portland | Oregon | 97239 | - |
| The University of Utah School of Medicine - Primary Children's Hospital (Primary Children's Medical Center) | Salt Lake City | Utah | 84113 | - |
| UW Valley Medical Center | Renton | Washington | 98055 | - |
Find similar trials in Baltimore, MD
By research site
Related Studies
- Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsPHASE3 · Recruiting · SK Life Science, Inc. · Palo Alto, California
- An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut SyndromePHASE3 · Recruiting · Epygenix · Little Rock, Arkansas
- Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut SyndromeRecruiting · Ann & Robert H Lurie Children's Hospital of Chicago · Chicago, Illinois